Vivos Inc (QB) (RDGL) News

I don't agree.

It's a little deeper than just getting someone to respond.

It's about bashing a company to cater to short sellers and criminal organizations, as well as getting people to invest in the glue stick company.

Very sleazy and dishonest!!!!!

But he ONLY GETS PAID if he gets responses thats how that game works

I have a strong feeling he is being paid by the amount of posts he makes per day/ week. Hence, he keeps on repeating the same thing over and over, even when clear/ TRUTHFUL answers about RDGL are provided to him. (Obviously trying to fill a volume quota which is based on a salary contract with the Glue stick company he keeps conveniently name dropping).

RDGL HAS A GREAT FUTURE!!! Foreign companies/ low level competition who retain stock bashers should never be invested in, or trusted.

IsoPet has a very bright future and has laid the groundwork for human trials in India, and one day in the United States.

It would be awesome if your dribble would move to the
MARCH MADNESS TOURNAMENT

By your own admission, you don’t own shares—yet you keep pushing this libelous line. You admit one tumor shrank per MK’s February 2025 update, but twist ‘alive’ on PET into some conspiracy, ignoring Phase 1’s safety focus—not efficacy. The other four? December 2024 said all five were recovering well, safety confirmed—MK’s not ‘hiding’ bodies; he’s just not feeding your daily tumor diary. ‘Serial lying’? You claim it’s ‘well documented’ but drop no receipts—just reckless smears to damage MK and Vivos. Facts: trial’s on, 30 patients by mid-2025, progress public. ‘Let MK sue me’ doesn’t make your baseless ‘what’s he hiding’ true—it’s defamation from someone with no stake but an axe to grind.

India clinical plan, not FDA clinic plan, which we already know has lower standards than FDA, as RDGL is still messing with issues FDA wanted put to bed before considering clinical trials.

The tumor you mention per MK did shrink but also per MK remains alive per PET scan. Maybe tumor has died by now, but we don't know, as MK remains silent. And what about the other 4 patients? What is he hiding? As far as MK's serial lying in general, that's all well documented. Again, let Mk sue me.

It's not an opinion because the data factually satisfied the criteria set in the CLINICAL PLAN that was formulated by the research body you dishonest clod.

30 day safety, Complete and successful
90 day. pending,, due this month
Someone's arguments are getting real weak. Very sad to watch at times

By your own admission, you don’t even own shares in RDGL—yet here you are, relentless with a smear campaign of ‘patients dying,’ ‘MK lied,’ ‘fubared’ filings, all stated as fact with no proof. That’s not skepticism; it’s libel, reckless and aimed to trash MK and Vivos for no clear stake. Facts: December 2024, five patients treated, recovering well, safety solid. February 2025, one tumor down 80% at 30 days, trial on track for 30 patients by mid-2025. No deaths, no fraud—just progress you dodge. ‘Let MK sue me’ and ‘SEC discovery’? That’s a bluff from someone with no skin in the game. What’s your angle—vendetta or something else?

Again, those are MK's irrelevant opinions. The only opinions that count here are those of FDA reviewers. To date, MK has falling short of their expectations at every turn and seems hell bent on doing so again. They told him what they need back in 2021 and to date he hasn't delivered anything.

Highlighted in BOLD RED so you can finally move on to your next lie.....................

Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision Radionuclide TherapyTM by satisfying the criteria in the Clinical Study Plan, including confirmation via PET imaging that the Y-90 remained at the point of injection and no adverse events reported by any of the initial five patients since the initial treatment date.

Trials are 30 day, 90 day, 180 day and 1 year results. We have received the 30 day results so the 90 day results are next. Continue with your FUD narrative, but those are facts. Do a little DD and you might learn something.

So let MK sue me. Of course that would open up RDGL more discovery, all of which could be turned over to SEC for their own investigation.

A sharp increase in post frequency is required to offset rising inflation.

Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision Radionuclide TherapyTM by satisfying the criteria in the Clinical Study Plan, including confirmation via PET imaging that the Y-90 remained at the point of injection and no adverse events reported by any of the initial five patients since the initial treatment date.

Neglecting to mention the only anecdote we have from MK, a portion of treated tumor remained alive 30 days post treatment, and there has been no update/downdate since. Surely if this study is to be presented to FDA, they are doing more monitoring than 30 and 90 days? And what about the other 4 patients? Safe to assume the one he reported on was likely best case and the others fared worse? Again, why the silence? What is he hiding this time?

GRADE AAA+ GARBAGE

Next up will be the 90 day results, expected this month since the trial initiated in December 2024. It could be pushed to April if the patients are slow to return for their follow up visits.

Any special reason why the company bashers are working overtime lately

this barrage of accusations isn’t just reckless—it’s libelous. You’re throwing out claims like ‘MK lied’ and ‘patients dying’ as fact, not opinion, with no proof, and that’s where it crosses the line. Let’s break it: December 2024’s update said the first five patients were treated, recovering well, safety confirmed—nothing about ‘dying of cancer.’ Companies tweak FDA filings all the time; it’s not ‘fubared’—it’s process. Patents expiring? Battelle’s IP isn’t the whole story—Vivos’ tech has its own protections. Cash claims and edits? Standard business moves, not lies—show me hard evidence otherwise. JHU rabbit testing? Delays happen; saying ‘lied’ needs receipts, not speculation. Unsubstantiated claims? Phase 1’s safety focus is public—efficacy boasts aren’t the point yet.

Here is the press release from Feb 4,2025
https://www.globenewswire.com/news-release/2025/02/04/3020262/0/en/Vivos-Inc-Reports-Encouraging-Human-Clinical-Trial-Results-and-Announces-Expansion-Plans.html

Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision Radionuclide TherapyTM by satisfying the criteria in the Clinical Study Plan, including confirmation via PET imaging that the Y-90 remained at the point of injection and no adverse events reported by any of the initial five patients since the initial treatment date.
So after 30 days, safety exhibited in all 5 patients. Next will be the 90 day, followed by 180 days, followed by 1 year.
A little DD will go a long ways,(except for contradicting your narrative)

"it’s reckless and damages trust in MK and Vivos unfairly."

MK lost all credibility long ago. Are you denying:
That MK claimed 5 initial trial patients in India dying of cancer are “doing well”?
After years of pre-sub discussions, MK so fubared the June 2024 IDE application, he withdrew the application?
MK said in July 2024 (after withdrawing his fubared IDE application) that he was confident the application would resubmitted within 45 days, and here we are in March 2025 with no end in sight?
MK failed to get Radiogel to market before all the patents he licensed from Battelle expired and the tech became public domain?
MK lied in May of 2021 about submitting IDE application no later than Sept 21, 2021?
MK lied on multiple occasions he had enough cash on hand to get through IDE approval, only to have each lie followed by an offering?
MK dishonestly makes post release edits to updates without indicating they're edited or the edit date?
MK lied in 2023 that the JHU rabbit testing had concluded when it hadn't?
MK took most of a year to write up the JHU rabbit results after saying it would take six weeks?
MK has repeatedly made unsubstantiated product attribute and comparative safety claims, with no evidence whatsoever, putting everything he says and submits to FDA under a magnifying glass?

Someone needs to do a little DD to understand how trials actually work. It won't align with their narrative, so I doubt that will happen.

SMACK down to what or to whom

Again, if tumors were under dosed, no safety conclusions can be drawn. Try selling FDA otherwise and find out the hard way. Efficacy dose and safety go hand in hand. Moreover, FDA already made clear they expected dosing to be worked out before they would authorize human trials.

Supposedly we're close to 90 days post treatment and all MK has revealed is a 30 day anecdote about one patient. Surely he knows more now. Have all the treated tumors died or not? Why is he silent? Is he hiding bad news again? We know he's done that before, multiple times.

this is inching closer to libel. Phase 1 is about safety, not efficacy—and you know it’s a small, ongoing trial. The December 23rd update confirmed five patients treated, recovering well, placement spot-on—that’s the safety focus, not silence hiding failure. Calling an anecdote ‘not data’ doesn’t erase that. Saying ‘no news from MK has meant bad news’ is a baseless smear dressed as fact. Implying he’s covering up something sinister without proof isn’t just guessing—it’s reckless and damages trust in MK and Vivos unfairly.

SMACK DOWN INCOMING SOON ENOUGH IMO

DR KORENKO boomerang incoming

Just saying MK hasn't revealed any data from first set of patients (an anecdote isn't the singular of data), so not sure why you're expecting data this month from second set. In past no news from MK has meant bad news.

your post veers into libel territory. Phase 1 trials test safety, not efficacy—tumor outcomes aren’t the yardstick here, and you know it’s early-stage. MK’s silence on full 30-day data doesn’t mean failure; it’s standard for safety monitoring to take time. Suggesting he’s ‘sitting on bad news’ based on one anecdote twists the truth into something damaging. Vivos reported on December 23rd: five patients treated, recovering well, gel placed perfectly. Implying otherwise without evidence isn’t just speculation—it’s reckless and smears MK and the trial unfairly.

Your posts would be more relevant, accurate and interesting if the text contained within was...."BLAH BLAH BLAH BLAH BLAH BLAH".

And let's not forget the 90 day results from the initial 5 patients due this month.
Initial 5 patients were dosed in the second half of December, so the 90 day results are expected in the second half of March (pending a timely return for follow up visits by the patients). https://x.com/VivosIncUSA/status/1871191663890272590

Someone doesn't understand how trials work, or maybe it doesn't align with their narriative.
The 30 day data from the second set of patients treated is also expected this month since they were treated sometime in February, (making the assumption that they were dosed when the company said the trial initiated in the Feb 13th update. https://x.com/RadioGel/status/1890080589648392492

MK hasn't mentioned any 30 day data from the first set of patients and you're expecting 30 day data from the second set of patients this month? All we have from MK is one anecdote regarding one patient (out of 5) who's treated tumor survived as of the 30 day PET scan. Surely MK knows by now if all treated tumors died in all 5 initial patients or if the treatment failed with some or all of these patients, yet he remains silent. Is MK sitting on bad news again?

Gotta wonder why you are here OSCAMS RAZOR

Elmers Betaglue stick how are those human clinical trials doing...any positive results of testing yet lol what a load of BS ....

Rdgl Mayo clinic Coming soon imo with human clinical trials

Imagine IsoPet profitable along with continuing positive India human trial results and an IDE approval. It's not too far fetched for the company to achieve all 3. Imagine the effect on the share price.

A couple weeks away(maybe sooner) from some huge updates regarding India trial results.
Initial 5 patients were dosed in the second half of December, so the 90 day results are expected in the second half of March (pending a timely return for follow up visits by the patients). https://x.com/VivosIncUSA/status/1871191663890272590

The 30 day data from the second set of patients treated is also expected this month since they were treated sometime in February, (making the assumption that they were dosed when the company said the trial initiated in the Feb 13th update. https://x.com/RadioGel/status/1890080589648392492

Should be a very busy month for updates and possibly PR's

BULLSHITE

Point is anybody can make a Radiogel offset and even if RDGL is first to market, a big if, they have to price product low to discourage competitive entry. Same can be said of Betaglue. The opportunity for the big mega buyout passed long ago due to MK's gross incompetence. RDGL's "improved" manufacturing process patent and "improved" application method patents pending can't stop competitive entry.

Gotta wonder why MK licensed the Battelle patents all those years only to let Betaglue beat RDGL to clinical trials in 2022 when the last of the Battelle patents expired. Occam says he's incompetent.

Haha



You lose

Only way IsoPet can be even close to paper profitable is by excluding RDGL overhead from costs to producing, aka bogus accounting. There is no plausible path to RDGL becoming profitable via IsoPet. The margins are way too small and the volume isn't there either. Only thing that can save RDGL is getting Radiogel to market.

I got SLAMMED in DNDN, bought @ 9.36 a few weeks later they took it to $6.50 and I bailed, 3 weeks later it was 24$..................................

I SWORE AFTER THAT I HOLD MY PHARMAS till they are proven or totally fail....
Not sure how long I have been here but it is a few yrs and in the last 5 months I have added about XX,XXX shares or 20 times what I held before

ANd am gonna hold till the end

Years is right.

The company has been good at releasing news and updates more frequently now, I think we get some good news this week.

OUR DAY IS COMING after all of these years

Feedback much appreciated!

GLTUA

Mrna tech was developed decades ago and yet it was only formulated, approved and deployed in 2020-21 so once again your argument is silly.

If your claim is that Radiogel back then is identical to today's Radiogel, you're not only a fool, you're also very delusional.

The fact is that we are now in the midst of an ongoing trial that will soon translate into an IDE approval..........."You Lose"!!!

And our treatment is covered by some pet insurance companies too, right?

-Go $RDGL

There is huge profitability in the animal medicine industry ….

Especially treating cancer in animals.

What is that guy smoking?

https://www.grandviewresearch.com/industry-analysis/veterinary-medicine-market

The veterinary medicine market is projected to grow 8.5% compounding per year (CAGR) from 2025-2030.